<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel disease</z:e> (IBD) is an important etiologic factor in the development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the mechanism underlying <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> through <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> is still unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Activation-induced <z:chebi fb="0" ids="17562">cytidine</z:chebi> deaminase (AID) is induced by the <z:mp ids='MP_0001845'>inflammation</z:mp> and involved in various human <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> via its mutagenic activity </plain></SENT>
<SENT sid="3" pm="."><plain>In the current study, we investigated whether the <z:mp ids='MP_0001845'>inflammation</z:mp>/AID axis plays an integral role in the development of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> in the cecum was more severe than that in other colonic regions, and endogenous AID expression was enhanced most prominently in the inflamed cecal mucosa of interleukin (IL)-10(-/-) mice </plain></SENT>
<SENT sid="5" pm="."><plain>Blockade of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-Î± and IL-12 significantly suppressed AID expression </plain></SENT>
<SENT sid="6" pm="."><plain>Although proinflammatory cytokine expression was comparable between IL-10(-/-)AID(+/+) and IL-10(-/-)AID(-/-) mice, sequencing analyses revealed a significantly lower incidence of <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in Trp53 gene in the colonic mucosa of IL-10(-/-)AID(-/-) than IL-10(-/-)AID(+/+) mice </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0003003'>Colon cancers</z:hpo> spontaneously developed in the cecum in 6 of 22 (27.2%) IL-10(-/-)AID(+/+) mice </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, none of the IL-10(-/-)AID(-/-) mice developed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> except only one case of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in the distal colon </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that the proinflammatory cytokine-induced aberrant production of AID links colonic <z:mp ids='MP_0001845'>inflammation</z:mp> to an enhanced genetic susceptibility to oncogenic mutagenesis </plain></SENT>
<SENT sid="10" pm="."><plain>Targeting AID could be a novel strategy to prevent <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> irrespective of ongoing colonic <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>